Pharmafile Logo
Pharmafocus logo
Advanced Search

A postcard from … Slovakia

October 10, 2008
Research and Development, Sales and Marketing Europe, Slovakia, hc

Feature

UK is example to Europe on patient information, says industry

October 9, 2008
Medical Communications patients

British pharma is free to provide necessary and sufficient information to patients about its drugs, and an example to be …

News

Lilly eyes oncology focus with ImClone acquisition

October 9, 2008
Sales and Marketing Cancer, MA, lilly

Lilly is to buy ImClone for $6.5 billion after outbidding Bristol-Myers Squibb for the biotech company. Lilly says the acquisition …

News

GlycArt’s new cancer candidate to be developed with Roche

October 9, 2008
Research and Development, Sales and Marketing GlycArt, Roche

Roche is to develop a potential cancer therapy with two business partners. Genentech, the Swiss biotech company GlycArt – wholly-owned …

News

Advertising start-up is UK’s ‘first virtual healthcare agency’

October 7, 2008
Medical Communications digi

A new advertising agency has been launched as the UK’s first ‘virtual’ healthcare outfit, and aims to undercut traditional agencies …

News

Norgine quits ABPI and denounces big pharma bias

October 6, 2008
Sales and Marketing ABPI, Norgine

News

Latest news from Datamonitor

October 6, 2008
Sales and Marketing OTC

Is an Rx-to-OTC move the right prescription to protect pharma revenues and cut healthcare costs? The growing cost of developing …

News

GSK plans research job losses in UK

October 3, 2008
Research and Development GSK, restructure

GlaxoSmithKline is set to cut about 850 jobs in early-stage research and development at sites across the world, including the …

News

Emerging confidence

October 2, 2008
Research and Development, Sales and Marketing emerging markets, evidence-based medicine

 The wisdom that emerging markets are vital to the pharmaceutical and biotechnology industry’s future has become a lot more conventional …

Feature

Osteoporosis drug Aclasta approved for use in men

October 2, 2008
Sales and Marketing Novartis, aclasta, osteoporosis

Osteoporosis treatment Aclasta has been approved for an extended indication in the European Union.Novartis’ once-yearly infusion has now been given …

News

Long-acting Zyprexa gets green light

October 2, 2008
Sales and Marketing lilly, psych

Lilly's Zypadhera has been recommended in Europe for use in stabilising schizophrenic patients who are already receiving treatment. The European …

News

Spiriva partners defend drug’s safety

October 2, 2008
Sales and Marketing Boehringer, COPD, Spiriva, resp

Boehringer Ingelheim and Pfizer have released new data on Spiriva to defend the safety record of the chronic obstructive pulmonary …

News

Weak currency helps UK pharmaceutical industry

October 1, 2008
Manufacturing and Production, Sales and Marketing parallel trade

Pharmaceutical companies operating in the UK are experiencing reduced competition from European parallel importers, thanks to the weakness of the …

News

Credit crunch hits European biotech

October 1, 2008
Research and Development 2008, YIR, biotech

Europe’s biotech sector is being hit hard by the credit crunch, with small and medium-sized companies being starved of funding …

News

Overcoming barriers to access

September 30, 2008
Sales and Marketing Europe, UK, market access, strategies

Feature

Latest news from Datamonitor

September 29, 2008
Sales and Marketing par

Is cost containment impacting pharmaceutical innovation?With the cost of healthcare provision spiraling, governments and payers across the seven major markets …

News

MHRA unveils medicine information resource

September 29, 2008
Medical Communications patients

UK regulators and the pharma industry have come together to launch a new website for patients. The 'mymedicine' site is …

News

Pradaxa approved by NICE

September 26, 2008
Sales and Marketing NICE, Pradaxa, clot, cv

NICE has recommended Boehringer Ingelheim's novel anti-clotting pill Pradaxa, giving it a marketing edge over Bayer's rival treatment Xarelto. Pradaxa …

News

Lilly to reveal doctor payments

September 26, 2008
Medical Communications, Sales and Marketing ethics

Lilly is to be the first pharmaceutical company to disclose payments made to US doctors for consultancy services and key …

News

Merck’s Kuvan set for European approval

September 26, 2008
Sales and Marketing EU, Kuvan

Merck Serono's Kuvan is on track to become the first medicine approved in Europe for two rare neurological disorders. Regulatory …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026